Skip to Main Content

Paper Details

Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma.
Sci Transl Med
144
2019
B cell lymphoma, Bruton, IACS-010759, MCL, cancer, cancer cell, cancers, complex I, ibrutinib, ibrutinib-resistant patient-derived cancer models, malignancies, mantle cell lymphoma, patient, relapsed, tyrosine, tyrosine kinase
Author NameAffiliation
Samuel G MackintoshUniversity of Arkansas for Medical Sciences
Xingzhi Songthe University of Texas MD Anderson Cancer Center
Xingzhi Songthe University of Texas MD Anderson Cancer Center
Jianhua Zhangthe University of Texas MD Anderson Cancer Center
Jianhua Zhangthe University of Texas MD Anderson Cancer Center
Timothy P HeffernanInstitute for Applied Cancer Science and Center for Co-Clinical Trials, the University of Texas MD Anderson Cancer Center
Phillip A Futrealthe University of Texas MD Anderson Cancer Center
Linghua Wangthe University of Texas MD Anderson Cancer Center
  • 1 - 8

Datasets

Release 1.2